Adamis Pharmaceuticals | ADMP - Przychody Ze Sprzedaży



Obroty Zmiana Data
Adma Biologics USD 139.16M 4.94M 2025-12
Alterity Therapeutics Limited AUD 11.38K 10.23K 2022-12
Brainstorm Cell Therapeutics 0 0 2025-03
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cipla INR 75.18B 710M 2025-12
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 67.33M 65.44M 2025-12
CSL USD 8.33B 4.79B 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Glaxosmithkline GBP 11.46B 59.16M 2025-12
Grifols EUR 2.34B 33.3M 2026-03
Merck USD 16.4B 880M 2025-12
Pfizer USD 17.58B 880M 2025-12
RedHill Biopharma USD 1.29M 722K 2024-06